Healthcare -
Biotechnology - NASDAQ - US
$ 1.8
-2.7 %
$ 393 M
Market Cap
-8.18
P/E
AKBA - COST OF REVENUE
Cost of Revenue AKBA - Akebia Therapeutics, Inc.
74.1 M
LAST VALUE
-30.47%
2 YEAR CAGR
57.36%
5 YEAR CAGR
0.00%
10 YEAR CAGR